SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-118177
Filing Date
2024-04-26
Accepted
2024-04-26 16:31:00
Documents
6
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d765074ddef14a.htm DEF 14A 405561
2 GRAPHIC g765074dsp043.jpg GRAPHIC 215925
3 GRAPHIC g765074dsp044.jpg GRAPHIC 92764
4 GRAPHIC g765074g01a36.jpg GRAPHIC 75005
5 GRAPHIC g765074g17x65.jpg GRAPHIC 595588
6 GRAPHIC g765074g35j54.jpg GRAPHIC 38253
  Complete submission text file 0001193125-24-118177.txt   1787701
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37783 | Film No.: 24884387
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)